8,12-iso-iPF2α-VI-d11
- $169 - $3845
- Product name: 8,12-iso-iPF2α-VI-d11
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:8,12-iso-iPF2α-VI-d11
6 prices
Selected condition:
Brand
- Cayman Chemical
- TRC
Package
- 10μg
- 25μg
- 50μg
- 1mg
- 2.5mg
- 5mg
- ManufacturerCayman Chemical
- Product number10006878
- Product description8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11)
- Packaging10μg
- Price$169
- Updated2022-04-27
- Buy
- ManufacturerCayman Chemical
- Product number10006878
- Product description8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11)
- Packaging25μg
- Price$402
- Updated2022-04-27
- Buy
- ManufacturerCayman Chemical
- Product number10006878
- Product description8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11)
- Packaging50μg
- Price$760
- Updated2022-04-27
- Buy
- ManufacturerTRC
- Product numberI874707
- Product description8,12-Iso-iPF2α-VI-d11
- Packaging1mg
- Price$910
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberI874707
- Product description8,12-Iso-iPF2α-VI-d11
- Packaging2.5mg
- Price$2015
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberI874707
- Product description8,12-Iso-iPF2α-VI-d11
- Packaging5mg
- Price$3845
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 10006878 | 8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11) | 10μg | $169 | 2022-04-27 | Buy |
Cayman Chemical | 10006878 | 8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11) | 25μg | $402 | 2022-04-27 | Buy |
Cayman Chemical | 10006878 | 8,12-iso-iPF2α-VI-d11 ≥99% deuterated forms (d1-d11) | 50μg | $760 | 2022-04-27 | Buy |
TRC | I874707 | 8,12-Iso-iPF2α-VI-d11 | 1mg | $910 | 2021-12-16 | Buy |
TRC | I874707 | 8,12-Iso-iPF2α-VI-d11 | 2.5mg | $2015 | 2021-12-16 | Buy |
TRC | I874707 | 8,12-Iso-iPF2α-VI-d11 | 5mg | $3845 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|